Literature DB >> 11906179

Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region.

Xiaoyang Sheng1, Dimpy Koul, Juinn-Lin Liu, Ta-Jen Liu, W K Alfred Yung.   

Abstract

Mutations of PTEN, a tumor suppressor gene located on chromosome 10, which encodes a protein-tyrosine and lipid-phosphatase, are prevalent in various human cancers, including glioblastoma. Despite extensive characterization of PTEN mutations in human cancers and a relatively good understanding of the molecular roles of PTEN in the control of cellular processes, little is known about modes of PTEN regulation. To understand the regulation of expression of the tumor suppressor gene PTEN, we isolated a 2212 bp fragment from the human BAC clone 46B12 DNA. The 3' end of this fragment starts at the Not I site of -745 relative to the first translation codon ATG (+1) and ends at the Sal I site of -2957 at the 5' end. Using classical 5'RACE and primer extension techniques, nine start sites were observed between -817 and -984 upstream of the ATG start site. We located a 137 bp fragment (-958/-821) as the minimum promoter region using promoter deletion and luciferase assays. A 704 bp fragment (-33/-737) downstream of the 2212 bp fragment was also cloned. As indicated by luciferase assays, the data show that this region possesses no promoter function. Interestingly, a p53 binding sequence is located within the 599 bp fragment (-1344/-745), although p53 expression had a minimal effect on PTEN, demonstrating its insignificant role in PTEN gene expression. (c)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906179     DOI: 10.1006/bbrc.2002.6662

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Down-regulation of PTEN expression due to loss of promoter activity in human hepatocellular carcinoma cell lines.

Authors:  Dong-Zhu Ma; Zhen Xu; Yu-Long Liang; Jian-Ming Su; Zeng-Xia Li; Wen Zhang; Li-Ying Wang; Xi-Liang Zha
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

2.  A novel PTEN gene promoter mutation and untypical Cowden syndrome.

Authors:  Chen Liu; Guangbing Li; Rongrong Chen; Xiaobo Yang; Xue Zhao; Haitao Zhao
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

3.  Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.

Authors:  Xiao-Ping Zhou; Kristin A Waite; Robert Pilarski; Heather Hampel; Magali J Fernandez; Cindy Bos; Majed Dasouki; Gerald L Feldman; Lois A Greenberg; Jennifer Ivanovich; Ellen Matloff; Annette Patterson; Mary Ella Pierpont; Donna Russo; Najah T Nassif; Charis Eng
Journal:  Am J Hum Genet       Date:  2003-07-03       Impact factor: 11.025

4.  Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.

Authors:  Jongchan Kim; Ashley N Siverly; Dahu Chen; Min Wang; Yuan Yuan; Yumeng Wang; Hyemin Lee; Jinsong Zhang; William J Muller; Han Liang; Boyi Gan; Xianbin Yang; Yutong Sun; M James You; Li Ma
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

5.  miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics.

Authors:  Nadav Bar; Rivka Dikstein
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

6.  Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer.

Authors:  Suzana S Couto; Mei Cao; Paulo C Duarte; Whitney Banach-Petrosky; Shunyou Wang; Peter Romanienko; Hong Wu; Robert D Cardiff; Cory Abate-Shen; Gerald R Cunha
Journal:  Differentiation       Date:  2008-10-16       Impact factor: 3.880

7.  ΔNp63α promotes the expression and nuclear translocation of PTEN, leading to cisplatin resistance in oral cancer cells.

Authors:  Ting Hao; Ye-Hua Gan
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

8.  Missense mutation in the PTEN promoter of a patient with hemifacial hyperplasia.

Authors:  Kiyomi Yamazaki; Charis Eng; Sergei A Kuznetsov; John Reinisch; Dennis-Duke Yamashita; John Walker; Craig Cheung; Pamela G Robey; Stephen L-K Yen
Journal:  Bonekey Rep       Date:  2015-07-29

9.  Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation.

Authors:  Rosemary E Teresi; Kevin M Zbuk; Marcus G Pezzolesi; Kristin A Waite; Charis Eng
Journal:  Am J Hum Genet       Date:  2007-08-15       Impact factor: 11.025

10.  Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma.

Authors:  Durmus Burgucu; Kenan Guney; Duygu Sahinturk; Irem Hicran Ozbudak; Deniz Ozel; Gulay Ozbilim; Ugur Yavuzer
Journal:  BMC Cancer       Date:  2012-10-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.